Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4d64e7795c81d0ada9b0a7ec1937833 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
filingDate |
2019-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68b743d8475bb3344c8d597f3387b48c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35dd412b20459553d532943daac19dda |
publicationDate |
2021-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021077570-A1 |
titleOfInvention |
Composition comprising a polymyxin and teicoplanin |
abstract |
The invention relates to a pharmaceutical composition comprising a polymyxin or a pharmaceutically acceptable salt or prodrug thereof, teicoplanin or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable excipient and to ready-to-use kits for the preparation of said pharmaceutical composition. |
priorityDate |
2018-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |